News in brief: Pharmacists concern over biosimilar switching letters; JSLE patients have neuropsychiatric symptoms; Aussie trial confirms convalescent plasma is futile for COVID-19 patients

Pharmacists concern over biosimilar switching letters Pharmacists have raised concerns about some rheumatologists who they claim are giving patients proforma letters supplied by Abbvie insisting that the originator Humira brand of adalimumab is dispensed rather than biosimilars. According to a report in The Australian, pharmacists said they felt it was inappropriate for doctors to use ...

Already a member?

Login to keep reading.

© 2021 the limbic